個別化医療の世界市場レポート 2025年

個別化医療の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.6％で6,626億7,000万米ドルに成長します。予測期間の成長は、ゲノムの継続的な進歩、バイオマーカー探索の拡大、遠隔医療の採用拡大、規制のサポートと枠組み、コラボレーションとデータ共有に起因しています。予測期間の主な動向には、人工知能（AI）の統合、ゲノム配列決定の進歩、データの統合と分析、免疫療法と標的療法、患者のエンパワーメントと情報に基づく意思決定、共同研究とパートナーシップなどが含まれます。

希少疾患の有病率の増加は、個別化医療市場の成長を促進すると予想されます。この増加は、クラインフェルター症候群、Aarskog症候群、Abetalipoproteinemiaなどの疾患と診断される個人の増加に関連しています。個別化医療は、希少疾患患者特有のニーズに対応した治療オプションを提供しています。例えば、2024年2月、英国を拠点とし、遺伝性疾患、希少疾患、未診断疾患に罹患している患者を支援する全国的な慈善団体である英国遺伝同盟は、英国では350万人が希少疾患とともに生活しており、17人に1人が人生のいずれかの時点で希少疾患に罹患する可能性があると報告しています。したがって、希少疾患の有病率は上昇を続けており、個別化医療市場の成長を後押ししています。

肥満の影響を受ける人口の拡大は、今後の個別化医療市場の成長を大きく促進する要因になると予測されています。肥満は、脂肪の異常な蓄積や過剰な蓄積を特徴とし、個人に健康上のリスクをもたらします。個別化医療は、肥満の原因となる特定の遺伝的・分子的要因に対処し、オーダーメイドの効果的な介入を可能にするという重要な役割を担っています。2022年3月現在、世界保健機関（WHO）は、世界で10億人以上が肥満であり、その内訳は、成人が6億5,000万人、青年が3億4,000万人、小児が3,900万人であると報告しています。WHOは、2025年までに約1億6,700万人の大人と子どもが、過体重または肥満によって健康状態が悪化すると予測しています。その結果、肥満の増加は個別化医療市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の個別化医療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の個別化医療市場：成長率分析
• 世界の個別化医療市場の実績：規模と成長, 2019-2024
• 世界の個別化医療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の個別化医療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の個別化医療市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 個別化医療診断
• 個別化医療治療
• パーソナライズされた医療
• パーソナライズされた栄養と健康
• 世界の個別化医療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経学
• 輸血の安全性
• 糖尿病
• 自己免疫疾患
• 心臓病学
• その他の用途
• 世界の個別化医療市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 研究・学術機関
• その他のエンドユーザー
• 世界の個別化医療市場、タイプ別サブセグメンテーション：個別化医療診断、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子検査
• バイオマーカー検査
• コンパニオン診断
• 分子イメージング
• 世界の個別化医療市場、タイプ別サブセグメンテーション：個別化医療治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的療法
• 遺伝子治療
• モノクローナル抗体
• 細胞・遺伝子治療製品
• 世界の個別化医療市場、タイプ別サブセグメンテーション：パーソナライズ医療、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスタマイズされた治療計画
• 患者中心のケアモデル
• デジタルヘルスソリューション
• 遠隔患者モニタリング
• 世界の個別化医療市場、タイプ別サブセグメンテーション：パーソナライズされた栄養と健康、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニュートリゲノミクス
• カスタマイズされたダイエットプラン
• サプリメントのパーソナライゼーション
• ライフスタイル修正プログラム

第7章 地域別・国別分析

• 世界の個別化医療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の個別化医療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 個別化医療市場：競合情勢
• 個別化医療市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Danaher Corporation
• Eli Lilly and Company
• Decode Genetics Inc.
• GE HealthCare Technologies Inc.
• Roche Diagnostics
• Genentech Inc.
• Biogen Inc.
• Illumina Inc.
• Qiagen N.V.
• Exact Sciences Corporation
• Myriad Genetics Inc.
• Verily Life Sciences LLC
• Guardant Health Inc.
• Tempus Labs

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 個別化医療市場2029：新たな機会を提供する国
• 個別化医療市場2029：新たな機会を提供するセグメント
• 個別化医療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Personalized medicine involves customizing medical treatment based on an individual's distinct genetic, environmental, and lifestyle factors, with the aim of preventing, diagnosing, and treating diseases in a more targeted manner. This approach strives to align the delivery of appropriate therapies with the specific needs of individual patients, ensuring that the right treatments are administered to the right individuals at the right time.

The primary products in personalized medicine comprise personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. Personalized medicine diagnostics involves the study of an individual's specific genetic, molecular, and clinical characteristics to inform the diagnosis, treatment, and management of their disease. This approach is utilized in various applications such as disease diagnosis, treatment selection, monitoring treatment response, and clinical trial selection. Personalized medicine finds applications in diverse medical fields including oncology, neurology, blood transfusion safety, diabetes, autoimmune diseases, cardiology, and others. These products are employed in hospitals, diagnostic centers, research and academic institutes, and various healthcare settings.

The personalized medicine market research report is one of a series of new reports from The Business Research Company that provides personalized medicine market statistics, including personalized medicine industry global market size, regional shares, competitors with a personalized medicine market share, detailed personalized medicine market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine industry. This personalized medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized medicine market size has grown rapidly in recent years. It will grow from $386.27 billion in 2024 to $426.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.

The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $662.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.

The increasing prevalence of rare diseases is anticipated to drive the growth of the personalized medicine market. This rise pertains to the growing number of individuals diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides tailored treatment options that cater to the specific needs of patients with rare diseases. For instance, in February 2024, the Genetic Alliance UK, a national charity based in the UK that supports individuals affected by genetic, rare, and undiagnosed conditions, reported that 3.5 million people in the UK are living with a rare condition, with 1 in 17 individuals likely to be affected by a rare condition at some point in their lives. Therefore, as the prevalence of rare diseases continues to rise, it is fueling the growth of the personalized medicine market.

The expanding population affected by obesity is anticipated to be a significant driver of the growth in the personalized medicine market in the future. Obesity, characterized by the abnormal or excessive accumulation of fat, poses health risks for individuals. Personalized medicine plays a crucial role in addressing the specific genetic and molecular factors contributing to obesity, enabling tailored and effective interventions. As of March 2022, the World Health Organization (WHO) reported that over 1 billion people worldwide are currently obese, with 650 million being adults, 340 million adolescents, and 39 million children. The WHO projects that by 2025, approximately 167 million adults and children will experience deteriorating health due to being overweight or obese. Consequently, the increasing prevalence of obesity stands as a key factor propelling the growth of the personalized medicine market.

Technological advancements have emerged as a prominent and widely embraced trend within the personalized medicine market. Major players in this sector are proactively integrating new technologies into their operations to fortify their market positioning. A notable example is OM1, a leading US-based healthcare company leveraging real-world data and artificial intelligence (AI) to support healthcare providers. In April 2023, OM1 secured a patent for its groundbreaking AI-powered platform designed to accelerate the field of personalized medicine. This cutting-edge technology harnesses the power of large-scale data analysis to extract meaningful insights pertaining to diagnoses, disease progression, and treatment responses. Its paramount significance lies in delivering customized healthcare inputs, thereby empowering informed decision-making for healthcare providers. Moreover, the platform expedites clinical trials by efficiently identifying suitable candidates, thereby contributing significantly to the progress of personalized medicine within the market.

Major players in the personalized medicine market are strategically concentrating on the introduction of innovative products, exemplified by the launch of real-world data programs geared towards enhancing precision medicine solutions in mental health. Real-world data programs involve the systematic collection and analysis of information derived from routine clinical practices and patient experiences, providing valuable insights to inform healthcare decisions and outcomes. A case in point is Tempus, a US-based technology company specializing in utilizing artificial intelligence for advancing precision medicine. In May 2022, Tempus unveiled Tempus N+, a psychiatric real-world data program that incorporates key features such as collaboration with academic medical institutions, an integrated operating system dedicated to mental health, secure data pipelines, and access to real-world data. Additionally, the program facilitates the expansion of psychiatric care through Electronic Medical Record (EMR) integration and pharmacogenomic testing.

In April 2023, 4D Molecular Therapeutics (4DMT), a clinical-stage gene therapy company based in the United States and dedicated to developing products for both rare and prevalent diseases, acquired the worldwide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc. for a sum of $140 million. This strategic acquisition marks a significant milestone in the field of personalized medicine, particularly in the treatment of rare and genetic diseases, with a specific focus on addressing geographic atrophy. By targeting the complement pathway, this acquisition has the potential to yield improvements in patient outcomes. Aevitas Therapeutics, Inc., also based in the United States, is a biopharmaceutical company specializing in the development and commercialization of gene therapies for complement-mediated diseases.

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine market consists of sales of topical creams, serums, dietary supplements, customized meal plans, nutritional products, and drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Personalized Medicine Diagnostics; Personalized Medicine Therapeutics; Personalized Medical Care; Personalized Nutrition and Wellness
• 2) By Application: Oncology; Neurology; Blood Transfusion Safety; Diabetes; Autoimmune Diseases; Cardiology; Other Applications
• 3) By End-use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Other End-Users
• Subsegments:
• 1) By Personalized Medicine Diagnostics: Genetic Testing; Biomarker Testing; Companion Diagnostics; Molecular Imaging
• 2) By Personalized Medicine Therapeutics: Targeted Therapies; Gene Therapies; Monoclonal Antibodies; Cell and Gene Therapy Products
• 3) By Personalized Medical Care: Tailored Treatment Plans; Patient-Centric Care Models; Digital Health Solutions; Remote Patient Monitoring
• 4) By Personalized Nutrition And Wellness: Nutrigenomics; Customized Diet Plans; Supplement Personalization; Lifestyle Modification Programs
• Companies Mentioned: Bayer AG; Novartis AG; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Medicine Market Characteristics

3. Personalized Medicine Market Trends And Strategies

4. Personalized Medicine Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Personalized Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Medicine Market Growth Rate Analysis
• 5.4. Global Personalized Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Medicine Total Addressable Market (TAM)

6. Personalized Medicine Market Segmentation

• 6.1. Global Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Personalized Medicine Diagnostics
• Personalized Medicine Therapeutics
• Personalized Medical Care
• Personalized Nutrition and Wellness
• 6.2. Global Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Blood Transfusion Safety
• Diabetes
• Autoimmune Diseases
• Cardiology
• Other Applications
• 6.3. Global Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Research and Academic Institutes
• Other End-Users
• 6.4. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medicine Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Biomarker Testing
• Companion Diagnostics
• Molecular Imaging
• 6.5. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medicine Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Therapies
• Gene Therapies
• Monoclonal Antibodies
• Cell and Gene Therapy Products
• 6.6. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medical Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tailored Treatment Plans
• Patient-Centric Care Models
• Digital Health Solutions
• Remote Patient Monitoring
• 6.7. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Nutrition And Wellness, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nutrigenomics
• Customized Diet Plans
• Supplement Personalization
• Lifestyle Modification Programs

7. Personalized Medicine Market Regional And Country Analysis

• 7.1. Global Personalized Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Medicine Market

• 8.1. Asia-Pacific Personalized Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Medicine Market

• 9.1. China Personalized Medicine Market Overview
• 9.2. China Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Medicine Market

• 10.1. India Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Medicine Market

• 11.1. Japan Personalized Medicine Market Overview
• 11.2. Japan Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Medicine Market

• 12.1. Australia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Medicine Market

• 13.1. Indonesia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Medicine Market

• 14.1. South Korea Personalized Medicine Market Overview
• 14.2. South Korea Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Medicine Market

• 15.1. Western Europe Personalized Medicine Market Overview
• 15.2. Western Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Medicine Market

• 16.1. UK Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Medicine Market

• 17.1. Germany Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Medicine Market

• 18.1. France Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Medicine Market

• 19.1. Italy Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Medicine Market

• 20.1. Spain Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Medicine Market

• 21.1. Eastern Europe Personalized Medicine Market Overview
• 21.2. Eastern Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Medicine Market

• 22.1. Russia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Medicine Market

• 23.1. North America Personalized Medicine Market Overview
• 23.2. North America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Medicine Market

• 24.1. USA Personalized Medicine Market Overview
• 24.2. USA Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Medicine Market

• 25.1. Canada Personalized Medicine Market Overview
• 25.2. Canada Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Medicine Market

• 26.1. South America Personalized Medicine Market Overview
• 26.2. South America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Medicine Market

• 27.1. Brazil Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Medicine Market

• 28.1. Middle East Personalized Medicine Market Overview
• 28.2. Middle East Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Medicine Market

• 29.1. Africa Personalized Medicine Market Overview
• 29.2. Africa Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Medicine Market Competitive Landscape And Company Profiles

• 30.1. Personalized Medicine Market Competitive Landscape
• 30.2. Personalized Medicine Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Medicine Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Danaher Corporation
• 31.3. Eli Lilly and Company
• 31.4. Decode Genetics Inc.
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Roche Diagnostics
• 31.7. Genentech Inc.
• 31.8. Biogen Inc.
• 31.9. Illumina Inc.
• 31.10. Qiagen N.V.
• 31.11. Exact Sciences Corporation
• 31.12. Myriad Genetics Inc.
• 31.13. Verily Life Sciences LLC
• 31.14. Guardant Health Inc.
• 31.15. Tempus Labs

32. Global Personalized Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Medicine Market

34. Recent Developments In The Personalized Medicine Market

35. Personalized Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer